Background: Herbal supplements containing Siberian ginseng (SBG; Eleutherococcus senticosus, ”eleuthero”), among other ingredients, are administered to horses to maintain health and wellbeing. SBG has been reported to cause hypertension, anxiety and hypoglycemia in humans and other species, but there are no published reports documenting events in horses. Objectives: The objective of the study was to determine if the administration of a supplement containing SBG results in hypertension, hyperactivity, anxiety, and/or hypoglycemia in horses. Methods: Sixteen clinically healthy adult Thoroughbred horses, housed in stalls and randomly assigned to treated (N=8; supplement pellets containing SBG, 1,000 mg, fed once daily for 28 days) or control (N=8; supplement pellets without SBG) groups. Blood work was evaluated and blood pressure, and movement in the stall were measured after feeding the SBG or control pellets. Horses were subjected to a novel object test (NOT) on days 0 and 28, two hours after administering the supplements. Anxiety scores were assigned by a masked observer based on the observed reaction to the NOT test. Horses were monitored daily for clinical signs or adverse events. Results: The supplement was readily consumed by the horses and no adverse effects were seen over the treatment period. Mean systolic blood pressure significantly (P<0.05) decreased in the SBG-treated group by day 15 and 28 when compared to Day 0. Anxiety scores, after the NOT, were not significantly different between treatment groups. There were no treatment effects on heart rate, blood values, including glucose, indicators of anemia and blood proteins, liver enzymes, kidney values, electrolytes or calcium. Mean body weight of the horses did not change during the study period. Conclusions: The supplement containing Siberian ginseng (1,000 mg, once daily) was readily consumed and the administration for 28 days did not cause health issues, or result in hypertension, increased anxiety, or hypoglycemia.